Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator

Funding Opportunity Number: EP-IDS-16-001 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 93.360Eligible Applicants Public and State controlled institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businessesSmall businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-OS-ASPRClosing Date: Apr 15, 2016Award Ceiling: $30,000,000Expected Number of Awards: 2Creation Date: Feb 17, 2016Funding Opportunity Description: The current pipeline of candidate antimicrobial products is insufficient to counter the threat of antimicrobial resistance . A novel collaborative model is needed to spur innovation and investment towards new antimicrobial products to repopulate the early development pipeline. In 2014, the United States Government released the National Strategy for Combating Antimicrobial Resistant Bacteria. A component of the National Strategy is to establish a Biopharmaceutical Accelerator for Combating Antibiotic-Resistant Bacteria [Accelerator] to fund Research and Development (R&D) activities to help progress candidate products from the proof-of-concept stage through pre-clinical devel...

Source: Grants.gov - February 18, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding